119 related articles for article (PubMed ID: 38678322)
1. [SRSF2 promotes glioblastoma cell proliferation by inducing alternative splicing of FSP1 and inhibiting ferroptosis].
Hua D; Zhou XX; Wang Q; Sun CY; Shi CJ; Luo WJ; Jiang ZD; Yu SZ
Zhonghua Bing Li Xue Za Zhi; 2024 May; 53(5):430-438. PubMed ID: 38678322
[No Abstract] [Full Text] [Related]
2. SRSF3-Regulated RNA Alternative Splicing Promotes Glioblastoma Tumorigenicity by Affecting Multiple Cellular Processes.
Song X; Wan X; Huang T; Zeng C; Sastry N; Wu B; James CD; Horbinski C; Nakano I; Zhang W; Hu B; Cheng SY
Cancer Res; 2019 Oct; 79(20):5288-5301. PubMed ID: 31462429
[TBL] [Abstract][Full Text] [Related]
3. CircSMARCA5 Inhibits Migration of Glioblastoma Multiforme Cells by Regulating a Molecular Axis Involving Splicing Factors SRSF1/SRSF3/PTB.
Barbagallo D; Caponnetto A; Cirnigliaro M; Brex D; Barbagallo C; D'Angeli F; Morrone A; Caltabiano R; Barbagallo GM; Ragusa M; Di Pietro C; Hansen TB; Purrello M
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29415469
[TBL] [Abstract][Full Text] [Related]
4. Serine-arginine splicing factor 2 promotes oesophageal cancer progression by regulating alternative splicing of interferon regulatory factor 3.
Wei Z; Wang Y; Ma W; Xing W; Lu P; Shang Z; Li F; Li H; Wang Y
RNA Biol; 2023 Jan; 20(1):359-367. PubMed ID: 37335045
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive analysis of RNA-binding protein SRSF2-dependent alternative splicing signature in malignant proliferation of colorectal carcinoma.
Liu W; Li D; Lu T; Zhang H; Chen Z; Ruan Q; Zheng Z; Chen L; Guo J
J Biol Chem; 2023 Feb; 299(2):102876. PubMed ID: 36623729
[TBL] [Abstract][Full Text] [Related]
6. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
McFarlane M; MacDonald AI; Stevenson A; Graham SV
J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103
[TBL] [Abstract][Full Text] [Related]
7. Orexin-A mediates glioblastoma proliferation inhibition by increasing ferroptosis triggered by unstable iron pools and GPX4 depletion.
Huan R; Zhang J; Yue J; Yang S; Han G; Cheng Y; Tan Y
J Cell Mol Med; 2024 May; 28(9):e18318. PubMed ID: 38685674
[TBL] [Abstract][Full Text] [Related]
8. HBV Enhances Sorafenib Resistance in Hepatocellular Carcinoma by Reducing Ferroptosis via SRSF2-Mediated Abnormal PCLAF Splicing.
Liu L; Lv Z; Wang M; Zhang D; Liu D; Zhu F
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834680
[TBL] [Abstract][Full Text] [Related]
9. DNA methylation-regulated LINC02587 inhibits ferroptosis and promotes the progression of glioma cells through the CoQ-FSP1 pathway.
Wang Z; Cui Y; Wang F; Xu L; Yan Y; Tong X; Yan H
BMC Cancer; 2023 Oct; 23(1):989. PubMed ID: 37848823
[TBL] [Abstract][Full Text] [Related]
10. Loss of COPZ1 induces NCOA4 mediated autophagy and ferroptosis in glioblastoma cell lines.
Zhang Y; Kong Y; Ma Y; Ni S; Wikerholmen T; Xi K; Zhao F; Zhao Z; Wang J; Huang B; Chen A; Yao Z; Han M; Feng Z; Hu Y; Thorsen F; Wang J; Li X
Oncogene; 2021 Feb; 40(8):1425-1439. PubMed ID: 33420375
[TBL] [Abstract][Full Text] [Related]
11. Serine/arginine rich splicing factor 2 expression and clinic pathological features indicating a prognostic factor in human hepatocellular carcinoma patients.
Wang P; Guo L; Li K; Ning S; Shi W; Liu Z; Chen Y
Cancer Biomark; 2018 Feb; 21(3):681-687. PubMed ID: 29278882
[TBL] [Abstract][Full Text] [Related]
12. SRSF2 Regulates Alternative Splicing to Drive Hepatocellular Carcinoma Development.
Luo C; Cheng Y; Liu Y; Chen L; Liu L; Wei N; Xie Z; Wu W; Feng Y
Cancer Res; 2017 Mar; 77(5):1168-1178. PubMed ID: 28082404
[TBL] [Abstract][Full Text] [Related]
13. CDCA7L promotes glioma proliferation by targeting CCND1 and predicts an unfavorable prognosis.
Ji QK; Ma JW; Liu RH; Li XS; Shen FZ; Huang LY; Hui L; Ma YJ; Jin BZ
Mol Med Rep; 2019 Aug; 20(2):1149-1156. PubMed ID: 31173217
[TBL] [Abstract][Full Text] [Related]
14. A novel antisense oligonucleotide anchored on the intronic splicing enhancer of hTERT pre-mRNA inhibits telomerase activity and induces apoptosis in glioma cells.
Wang F; Cheng Y; Zhang C; Chang G; Geng X
J Neurooncol; 2019 May; 143(1):57-68. PubMed ID: 30887243
[TBL] [Abstract][Full Text] [Related]
15. [Inhibitory effects of siRNA targeting epidermal growth factor receptor on proliferation and invasion of human glioblastoma cells].
Kang CS; Pu PY; Wang GX; Li YH; Dong L; Wang H
Zhonghua Yi Xue Za Zhi; 2004 Sep; 84(18):1503-8. PubMed ID: 15500708
[TBL] [Abstract][Full Text] [Related]
16. CircLRFN5 inhibits the progression of glioblastoma via PRRX2/GCH1 mediated ferroptosis.
Jiang Y; Zhao J; Li R; Liu Y; Zhou L; Wang C; Lv C; Gao L; Cui D
J Exp Clin Cancer Res; 2022 Oct; 41(1):307. PubMed ID: 36266731
[TBL] [Abstract][Full Text] [Related]
17. Myelodysplasia-associated mutations in serine/arginine-rich splicing factor SRSF2 lead to alternative splicing of CDC25C.
Skrdlant L; Stark JM; Lin RJ
BMC Mol Biol; 2016 Aug; 17(1):18. PubMed ID: 27552991
[TBL] [Abstract][Full Text] [Related]
18. Splicing factor SRSF1 promotes gliomagenesis via oncogenic splice-switching of MYO1B.
Zhou X; Wang R; Li X; Yu L; Hua D; Sun C; Shi C; Luo W; Rao C; Jiang Z; Feng Y; Wang Q; Yu S
J Clin Invest; 2019 Feb; 129(2):676-693. PubMed ID: 30481162
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-670-3p suppresses ferroptosis of human glioblastoma cells through targeting ACSL4.
Bao C; Zhang J; Xian SY; Chen F
Free Radic Res; 2021 Jul; 55(7):853-864. PubMed ID: 34323631
[TBL] [Abstract][Full Text] [Related]
20. Activation of Cryptic 3' Splice-Sites by SRSF2 Contributes to Cassette Exon Skipping.
Moon H; Jang HN; Liu Y; Choi N; Oh J; Ha J; Zheng X; Shen H
Cells; 2019 Jul; 8(7):. PubMed ID: 31295920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
